Andhra Pradesh

13 February 2013

REVIEW ON STEM CELL THERAPY FOR DIABETES

About Author:
Kambham Venkateswarlu
Final Year Graduate Student
Sri Lakshmi Narasimha College of Pharmacy,
Palluru, Chittoor-517132, Andhra Pradesh, India.
k.v.reddy9441701016@gmail.com

ABSTRACT:
It is the branch of medicine that involves introducing new cells into a diseased tissue to trigger the body’s ability to heal itself.
Cell therapy includes stem cell therapy, which means harvesting, transplantating or implanting stem cells in order to make healing mechanisms available in the diseased or damaged tissue itself. These stem cells may be harvested from the body of the mature adult from specialized sites where it is available such as the marrow of large bones or they may be preserved stem cells, harvested from the Umbilical cord blood or cord tissue at the time of that person’s birth.
They may also be from another donor. If the donor of the stem cells is the same as the patient in whom it is transplanted, it is called autologous cell therapy. If the donor is a different person, it is called allogenic stem cell therapy.

12 February 2013

Require M.Pharm for Senior Executive/Manager-Regulatory Affairs - 2 posts

Formula HR consulting, Reputed pharmaceutical company

Post: Senior Executive/Manager-Regulatory Affairs- 2 No.'s

12 February 2013

Opening for Assistant General Manager- EHS through FORMULA HR CONSULTING

Reputed pharma cllient of FORMULA HR CONSULTING PVT LTD, Manufacturing of solid dosages and injectables

Post: Assistant General Manager- EHS

12 February 2013

Work as Purchase / Logistics / Supply Chain- Manager Leading Hyderabad based manufacturer of APIs

Leading Hyderabad based manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemistry related services. We are more than 1000 employees strong and our core competence lies in the application of strong process chemistry to manufacturing in regulatory environment.

11 February 2013

Jr Technical Officer – Compression (5 positions) needed in MNC Company

MNC Company through Formula Hr Consulting

Post: Junior Technical Officer – Compression (5 positions)

11 February 2013

Opportunity for Jr technical officer- Tablet inspection {5 posts} in MNC client of Formula HR Consulting

Formula Hr Consulting Pvt. Ltd at MNC Company

Post: Junior technical officer- Tablet inspection( 5 positions)

11 February 2013

Vacancies for Junior Technical Officer – Granulation in MNC client of Formula HR Consulting - 5 posts

For our MNC Client.

Post: Junior Technical Officer – Granulation (5 positions)

11 February 2013

Work as Business Development Manager in MNC

Reputed MNC client

Post: Business Development Manager

11 February 2013

THE ROLE OF COX-2 INHIBITORS IN HUMAN CANCER PREVENTION AND OTHER NOVEL TARGETS - A RECENT REVIEW

About Authors:
Lohithasu Duppala^*1, Madhu priya Damuluri¹, Anil kumar vadda^2

1GITAM Institute of Pharmacy, GITAM University, Pharmaceutics, visakhapatnam, Andhra Pradesh, India-530045.²AVANTHI Institute of pharmaceutical sciences, pharmacology, visakhapatnam, Andhra Pradesh, India-530045.^*lohithasu@gmail.com, anilkumar.vadda@gmail.com

ABSTRACT:
COX-2 (Cyclooxygenase-2) is a selective inhibitor of non-steroidal anti-inflammatory drug (NSAID). Cyclooxygenase -2, an enzyme responsible for inflammation and pain. Celecoxib, Rofecoxib, valdecoxib, Parecoxib are class of COX-2 inhibiting drugs. COX-2 inhibitors have been revealed to reduce the occurrence of cancers and pre-cancerous growths. Celecoxib, cox-2 inhibitor isused to prevention of polyp formation in Familial Adenomatous Polyposis (FAP). COX-2 inhibitors like celecoxib, Rofecoxib, valdecoxib, Parecoxibare currently being studied in cancer treatment and other targets. This review highlights the COX-2 inhibitors with special emphasis on their role in various kinds of cancer prevention and other targeted therapy. COX-2 inhibitors in cancer chemotherapy and neurological diseases like Parkinson and Alzheimer’s diseases still continues to attract researches on the development of COX-2 inhibitors.